Nils L. Johansen

Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration

Lotte Bjerre Knudsen, Per F. Nielsen, Per Olaf Huusfeldt et al. · Journal of Medicinal Chemistry · 2000 · 681 citations · Full text

Peptide Engineering, Glycobiology, Once Daily Administration +21

Structure−Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives:  Importance of Fatty Acid Length, Polarity, and Bulkiness

Kjeld Madsen, Lotte Bjerre Knudsen, Henrik Agersoe et al. · Journal of Medicinal Chemistry · 2007 · 239 citations

REMOVAL OF t‐BUTYL AND t‐BUTOXYCARBONYL PROTECTING GROUPS WITH TRIFLUOROACETIC ACID

Behrend F. Lundt, Nils L. Johansen, Aage Vølund et al. · International journal of peptide & protein research · 1978 · 160 citations

Chemical Engineering, Bioorganic Chemistry, Engineering +12

Designing synthetic superagonists of C3a anaphylatoxin

Julia A. Ember, Nils L. Johansen, Tony E. Hugli · Biochemistry · 1991 · 77 citations

Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone

Peter Thygesen, Henrik Sune Andersen, Carsten Behrens et al. · Growth Hormone & IGF Research · 2017 · 39 citations

Growth Hormone, Human Growth, Medicine +5